Event Recordings
Day 1 | Day 2
Day 2 Welcome
Joseph Wu, MD, PhD, Director, Stanford Cardiovascular Institute, Simon H. Stertzer, MD, Professor of Medicine and Radiology, Stanford University
Session VI: COVID-19 Industry and Societal Shifts
Moderators: Andrew Plump, MD, PhD, and Julie Parsonnet, MD
The Clinical Trial Enterprise: Lessons from a Pandemic
Janet Woodcock, MD, Acting Commissioner, FDA
Learnings from the Development of the BNT162b2 mRNA COVID-19 Vaccine
Kathrin Jansen, PhD, Senior Vice President, Head of Vaccine Research and Development, Pfizer
COVID-19: It’s the End of the World as We Know it…
Anne Heatherington, PhD, Senior Vice President, Head of Data Sciences Institute, Takeda
Development of the Moderna COVID-19 Vaccine (mRNA-1273)
Andrea Carfi, PhD,Chief Scientific Officer for Infectious Disease at Moderna
Panel Discussion
Moderators: Andrew Plump, MD, PhD, and Julie Parsonnet, MD
Featuring:
Janet Woodcock, MD
Acting Commissioner, FDA
Andrea Carfi, PhD
Vice President and Head of Research, Infectious Disease, Moderna, Inc.
Kathrin Jansen, PhD
Senior Vice President, Head of Vaccine Research and Development, Pfizer
Anne Heatherington, PhD
Senior Vice President, Head of Data Sciences Institute, Takeda
Session VII: Stanford Drug Discovery Showcase
Moderators: Camille Samuels, MBA, and Sanjay Malhotra, PhD
The Cardiac Myosin Activator, Omecamtiv Mecarbil: From Concept to Clinic
Fady Malik, MD, PhD, Executive Vice President, Research and Development, Cytokinetics
Mastering Biology to Advance Human Health
Serge Saxonov, PhD, Co-Founder and CEO, 10X Genomics
Mir Imran, MS
Chairman and CEO
Rani Therapeutics
A Brief, Recent History of Drug Discovery in AAV Gene Therapy
Ken Mills, President and CEO, REGENXBIO
Panel Discussion
Moderators: Camille Samuels, MBA, and Sanjay Malhotra, PhD
Featuring:
Fady Malik, MD, PhD
Executive Vice President, Research and Development, Cytokinetics
Serge Saxonov, PhD
Co-Founder and CEO, 10X Genomics
Mir Imran, MS
Chairman and CEO, Rani Therapeutics
Ken Mills
President and CEO, REGENXBIO
Session VIII: Discovery Research II
Moderators: Marc Tessier-Lavigne, PhD, and Kuldev Singh, MD
The VelociSuite Platform for COVID-19 Antiviral Therapy
George Yancopoulos, MD, PhD,President & CSO, Regeneron
Creating Transformational Medicines
Mathai Mammen, MD, PhD, Global Head of Research and Development, Janssen Pharmaceutical Companies of Johnson & Johnson
Towards Personalized Healthcare in Therapeutic Development
Levi Garraway, MD, PhD, CMO, Genentech
Data Convergence and Innovation Medicine
Thomas Hudson, MD, Senior Vice President, R&D and Chief Scientific Officer, AbbVie
Panel Discussion
Moderators: Marc Tessier-Lavigne, PhD, and Kuldev Singh, MD
Featuring:
George Yancopoulos, MD, PhD
President & CSO, Regeneron
Joan Mannick, MD
Head of Research and Development, Life Biosciences
Mathai Mammen, MD, PhD
Global Head of Research and Development, Janssen Pharmaceutical Companies of Johnson & Johnson
Levi Garraway, MD, PhD
CMO, Genentech
Thomas Hudson, MD
Senior Vice President, R&D and Chief Scientific Officer, AbbVie
Session IX: Health Policy
Moderators: Lloyd Minor, MD, and Woodrow A. Myers, Jr., MD, MBA
Fireside Chat with Woodrow A. Myers, Jr., MD, MBA
Helene Gayle, MD, MPH, President & CEO, The Chicago Community Trust
Disruptive Innovation in Health Care: In Memory of Clayton Christensen
Mark Smith, MD, MBA, Founding President & CEO, California Healthcare Foundation
Drug Discovery and Bioinnovation: Opportunities and Challenges
Elias Zerhouni, MD, Former President for R&D, Sanofi; former Director of the NIH; former U.S. Presidential Science Envoy
The Post-COVID Crisis in CV Disease – Policy Implications for Drug Development and Lifecycle Management
Robert Califf, MD, Head of Strategy and Policy, Verily Life Sciences and Google Health Divisions of Alphabet
Panel Discussion
Moderators: Lloyd Minor, MD, and Woodrow A. Myers, Jr., MD, MBA
Featuring:
Helene Gayle, MD, MPH
President & CEO, The Chicago Community Trust
Mark Smith, MD, MBA
Founding President & CEO, California Healthcare Foundation
Elias Zerhouni, MD
Former President for R&D, Sanofi; former Director of the NIH; former U.S. Presidential Science Envoy
Robert Califf, MD
Head of Strategy and Policy, Verily Life Sciences and Google Health Divisions of Alphabet
Closing Remarks Day 2
Joseph Wu, MD, PhD, Director, Stanford Cardiovascular Institute, Simon H. Stertzer, MD, Professor of Medicine and Radiology, Stanford University